{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:45:36Z","timestamp":1790142336435,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bone.2020.115612","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:46:12Z","timestamp":1598305572000},"page":"115612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Preserved postprandial suppression of bone turnover markers, despite increased fasting levels, in postmenopausal women"],"prefix":"10.1016","volume":"143","author":[{"given":"Julie","family":"Abildgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorkil","family":"Ploug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette T\u00f8nnes","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente Klarlund","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bone.2020.115612_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group","volume":"339","author":"Cummings","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0010","first-page":"2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures","volume":"83","author":"Ettinger","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2020.115612_bb0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1359\/jbmr.2005.20.5.886","article-title":"How many women have osteoporosis? JBMR anniversary classic. JBMR, volume 7, number 9, 1992","volume":"20","author":"Melton","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115612_bb0020","author":"WHO"},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0025","first-page":"50","article-title":"Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women","volume":"4","author":"Garnero","year":"2004","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"3","key":"10.1016\/j.bone.2020.115612_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00774-003-0472-0","article-title":"Microcracks: an alternative index for evaluating bone biomechanical quality","volume":"22","author":"Dai","year":"2004","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.bone.2020.115612_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S8756-3282(01)00662-7","article-title":"Mechanism of circadian variation in bone resorption","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone."},{"issue":"3","key":"10.1016\/j.bone.2020.115612_bb0045","first-page":"476","article-title":"Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women","volume":"74","author":"Schlemmer","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2020.115612_bb0050","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1210\/jc.2002-021447","article-title":"Octreotide abolishes the acute decrease in bone turnover in response to oral glucose","volume":"88","author":"Clowes","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115612_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bone.2017.01.027","article-title":"Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects","volume":"97","author":"Westberg-Rasmussen","year":"2017","journal-title":"Bone."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0060","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/00365520601137272","article-title":"Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate","volume":"42","author":"Holst","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bone.2020.115612_bb0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bone.2019.05.014","article-title":"GLP-2 and GIP exert separate effects on bone turnover: a randomized, placebo-controlled, crossover study in healthy young men","volume":"125","author":"Skov-Jeppesen","year":"2019","journal-title":"Bone."},{"issue":"4","key":"10.1016\/j.bone.2020.115612_bb0070","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1210\/jc.2013-3766","article-title":"A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk","volume":"99","author":"Torekov","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2020.115612_bb0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone."},{"issue":"8","key":"10.1016\/j.bone.2020.115612_bb0080","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2020.115612_bb0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bcp.13167","article-title":"The use of incretins and fractures \u2014 a meta-analysis on population-based real life data","volume":"83","author":"Driessen","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bone.2020.115612_bb0090","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00198-018-4649-8","article-title":"Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials","volume":"29","author":"Zhang","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2020.115612_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115612_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2018.03.016","article-title":"Bone turnover markers after the menopause: T-score approach","volume":"111","author":"Gossiel","year":"2018","journal-title":"Bone."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0105","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.2012-4113","article-title":"Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity","volume":"98","author":"Sowers","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2020.115612_bb0110","first-page":"3366","article-title":"Bone turnover markers and bone density across the menopausal transition","volume":"81","author":"Ebeling","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2020.115612_bb0115","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00198-012-1955-4","article-title":"Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis","volume":"23","author":"Michalska","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2020.115612_bb0120","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1096\/fj.201600825RRR","article-title":"REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation","volume":"32","author":"Song","year":"2018","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.bone.2020.115612_bb0125","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1210\/jc.2018-00554","article-title":"Ectopic lipid deposition is associated with insulin resistance in postmenopausal women","volume":"103","author":"Abildgaard","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2020.115612_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235174","article-title":"Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women","volume":"15","author":"Abildgaard","year":"2020","journal-title":"PLoS One"},{"issue":"Pt 4","key":"10.1016\/j.bone.2020.115612_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/000456329002700401","article-title":"What is 75\u00a0g of glucose?","volume":"27","author":"Wiener","year":"1990","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bone.2020.115612_bb0140","author":"WHO"},{"issue":"4","key":"10.1016\/j.bone.2020.115612_bb0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans","volume":"43","author":"Orskov","year":"1994","journal-title":"Diabetes."},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0196-9781(99)00176-X","article-title":"Structure, measurement, and secretion of human glucagon-like peptide-2","volume":"21","author":"Hartmann","year":"2000","journal-title":"Peptides."},{"issue":"8","key":"10.1016\/j.bone.2020.115612_bb0155","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1210\/jc.2011-0266","article-title":"Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans","volume":"96","author":"Lindgren","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115612_bb0160","author":"Fund DTDA"},{"key":"10.1016\/j.bone.2020.115612_bb0165","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bonekey.2014.68","article-title":"Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state","volume":"3","author":"Gossiel","year":"2014","journal-title":"Bonekey Rep."},{"issue":"6719","key":"10.1016\/j.bone.2020.115612_bb0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.bone.2020.115612_bb0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","article-title":"A meta-analysis of reference markers of bone turnover for prediction of fracture","volume":"94","author":"Johansson","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1210\/jc.2017-01949","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia","volume":"103","author":"Christensen","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115612_bb0185","unstructured":"Hartmann ANSMKSJLBMHUBAJJHMMRB. A pilot study showing acute inhibitory effect of GLP-1 on the bone resorption marker CTX in humans. JBMR Plus."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0190","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/jc.2019-00008","article-title":"Separate and combined effects of GIP and GLP-1 infusions on bone metabolism in overweight men without diabetes","volume":"104","author":"Bergmann","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2020.115612_bb0195","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2020.115612_bb0200","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.gme.0000172266.47820.43","article-title":"Effect of hormone therapy on the enteroinsular axis","volume":"12","author":"Sztefko","year":"2005","journal-title":"Menopause."},{"issue":"1 Pt 1","key":"10.1016\/j.bone.2020.115612_bb0205","first-page":"G171","article-title":"Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats","volume":"268","author":"Chen","year":"1995","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0016-5085(89)90758-0","article-title":"Influence of gender and menopause on gastric emptying and motility","volume":"96","author":"Hutson","year":"1989","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.bone.2020.115612_bb0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2337\/dc12-1609","article-title":"Relationships between gastric emptying, postprandial glycemia, and incretin hormones","volume":"36","author":"Marathe","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.bone.2020.115612_bb0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","article-title":"Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women","volume":"40","author":"Henriksen","year":"2007","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115612_bb0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6904-8-12","article-title":"Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin","volume":"8","author":"Karsdal","year":"2008","journal-title":"BMC Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.bone.2020.115612_bb0230","doi-asserted-by":"crossref","first-page":"E1227","DOI":"10.1152\/ajpendo.00492.2012","article-title":"Menopause is associated with decreased whole body fat oxidation during exercise","volume":"304","author":"Abildgaard","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3 Pt 1","key":"10.1016\/j.bone.2020.115612_bb0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.gme.0000247014.56254.12","article-title":"Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women","volume":"14","author":"Otsuki","year":"2007","journal-title":"Menopause."},{"issue":"4","key":"10.1016\/j.bone.2020.115612_bb0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"163","author":"Park","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0245","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db14-1751","article-title":"GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study","volume":"64","author":"Faerch","year":"2015","journal-title":"Diabetes."},{"issue":"4","key":"10.1016\/j.bone.2020.115612_bb0250","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2008-2197","article-title":"Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans","volume":"94","author":"Vollmer","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2020.115612_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jc.2015-3133","article-title":"Glucose-dependent insulinotropic polypeptide is associated with lower low-density lipoprotein but unhealthy fat distribution, independent of insulin: the ADDITION-PRO study","volume":"101","author":"Moller","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115612_bb0260","doi-asserted-by":"crossref","first-page":"115230","DOI":"10.1016\/j.bone.2020.115230","article-title":"Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity","volume":"133","author":"Fuglsang-Nielsen","year":"2020","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2020.115612_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/jc.2008-1455","article-title":"Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus","volume":"94","author":"Kanazawa","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0270","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1515\/JPEM.2010.23.7.697","article-title":"Decreased bone turnover in children and adolescents with well controlled type 1 diabetes","volume":"23","author":"Maggio","year":"2010","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2020.115612_bb0275","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1210\/jc.2018-00260","article-title":"Older subjects with beta-cell dysfunction have an accentuated incretin release","volume":"103","author":"de Jesus","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:58:48Z","timestamp":1757613528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220303926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":55,"alternative-id":["S8756328220303926"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115612","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preserved postprandial suppression of bone turnover markers, despite increased fasting levels, in postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115612"}}